Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life
Anju Keetharuth, Tracey Young(University of Sheffield), Marc Serfaty(Faculty (United Kingdom)), Ammar Al‐Chalabi(King's College London), Robert Howard(University College London), Laura H. Goldstein(Boston Medical Center), Christopher D. Graham(NHS Lothian), Emily Turton(University of Sheffield), Christopher McDermott(University of Sheffield), Charlotte Rawlinson(University College London), Matthew Bursnall(University of Sheffield), Lance M. McCracken(Uppsala University), Paul Tappenden(University of Sheffield), David White(University of Sheffield), Benjamin J. Thompson(University of Sheffield), Rebecca L. Gould(The London College), Mike Bradburn(University of Sheffield), Cindy Cooper(Department of Health and Social Care), Vanessa Lawrence(King's College London), Pavithra Kumar(University of Sheffield)
Cited by 2
Related Papers
Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable
|Statistical Methods in Medical Research|2015|2k
What is a pilot or feasibility study? A review of current practice and editorial policy
|BMC Medical Research Methodology|2010|1.6k
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
|Science|2015|980
Plastic waste associated with disease on coral reefs
|Science|2018|844
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
|New England Journal of Medicine|2012|774